“Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics-Reference-Cited by-同舟云学术

“Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics

Published:2007-08-20 Issue:5 Volume:179 Page:3325-3331
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Stebbings Richard,Findlay Lucy,Edwards Cherry,Eastwood David,Bird Chris,North David,Mistry Yogesh,Dilger Paula,Liefooghe Emily,Cludts Isabelle,Fox Bernard,Tarrant Gill,Robinson Jane,Meager Tony,Dolman Carl,Thorpe Susan J.,Bristow Adrian,Wadhwa Meenu,Thorpe Robin,Poole Stephen

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference14 articles.

1. Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

2. 2.6.14. Bacterial endotoxins. European Pharmacopoeia 5th Ed.2005 161-165. Council of Europe, Strasbourg, France.

3. A rapid ‘one-plate’ in vitro test for pyrogens

4. Monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs: test design and data analysis

5. 2.6.8. Pyrogens. European Pharmacopoeia 5th Ed.2005 152 Council of Europe, Strasbourg, France.

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors;International Immunopharmacology;2024-09

2. Preclinical Efficacy of VTX-0811: A Humanized First-in-Class PSGL-1 mAb Targeting TAMs to Suppress Tumor Growth;Cancers;2024-08-06

3. CD28 co-stimulation: novel insights and applications in cancer immunotherapy;Nature Reviews Immunology;2024-07-25

4. Immune‐related adverse events of antibody‐based biological medicines in cancer therapy;Journal of Cellular and Molecular Medicine;2024-07

5. Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation;PLOS ONE;2024-06-26